Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 36.81%-37.08M | ---- | -264.36%-58.67M | ---- | -10,635.33%-16.1M | ---- | -204.17%-150K | ---- | 101.77%144K |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -25.00%-5K | ---- | 60.00%-4K | ---- | 65.52%-10K | ---- | 14.71%-29K | ---- | 85.02%-34K |
| Interest expense - adjustment | ---- | 1.51%5.86M | ---- | -21.66%5.77M | ---- | -8.88%7.37M | ---- | 47.45%8.08M | ---- | 122.75%5.48M |
| Impairment and provisions: | ---- | -69.62%17.11M | ---- | 26,983.17%56.33M | ---- | --208K | ---- | ---- | ---- | -122.34%-103K |
| -Other impairments and provisions | ---- | -69.62%17.11M | ---- | 26,983.17%56.33M | ---- | --208K | ---- | ---- | ---- | -496.15%-103K |
| Revaluation surplus: | ---- | 7.94%2.01M | ---- | 231.08%1.86M | ---- | 48.27%-1.42M | ---- | ---2.75M | ---- | ---- |
| -Other fair value changes | ---- | 7.94%2.01M | ---- | 231.08%1.86M | ---- | 48.27%-1.42M | ---- | ---2.75M | ---- | ---- |
| Depreciation and amortization: | ---- | -17.61%24.03M | ---- | -4.85%29.16M | ---- | 1.78%30.65M | ---- | 44.62%30.11M | ---- | 12.72%20.82M |
| Financial expense | ---- | 9.52%23K | ---- | -4.55%21K | ---- | 0.00%22K | ---- | -4.35%22K | ---- | -68.92%23K |
| Special items | ---- | ---- | ---- | ---- | ---- | -47.56%-574K | ---- | 68.09%-389K | ---- | -2,808.89%-1.22M |
| Operating profit before the change of operating capital | ---- | -65.33%11.95M | ---- | 71.21%34.47M | ---- | -42.31%20.14M | ---- | 38.97%34.9M | ---- | 90.75%25.11M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 30.00%-28K | ---- | -900.00%-40K | ---- | 101.91%5K | ---- | -739.02%-262K | ---- | -36.92%41K |
| Accounts receivable (increase)decrease | ---- | 455.98%14.54M | ---- | 121.39%2.62M | ---- | -71.07%-12.23M | ---- | -79,322.22%-7.15M | ---- | -100.79%-9K |
| Accounts payable increase (decrease) | ---- | -555.40%-1.94M | ---- | -90.27%426K | ---- | -17.17%4.38M | ---- | 366.31%5.29M | ---- | 138.82%1.13M |
| Advance payment increase (decrease) | ---- | ---- | ---- | 274.94%768K | ---- | -148.24%-439K | ---- | 146.17%910K | ---- | -866.18%-1.97M |
| Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---377K |
| Cash from business operations | ---- | -35.88%24.52M | ---- | 222.64%38.24M | ---- | -64.82%11.85M | ---- | 40.77%33.69M | ---- | 39.45%23.93M |
| Other taxs | ---- | 91.76%-254K | ---- | -23.07%-3.08M | ---- | 23.91%-2.51M | ---- | 15.44%-3.29M | ---- | -7.81%-3.89M |
| Special items of business | -217.30%-20.79M | ---- | 3.86%17.72M | ---- | 243.46%17.06M | ---- | 7.95%4.97M | ---- | 20,818.18%4.6M | ---- |
| Net cash from operations | -217.30%-20.79M | -30.98%24.27M | 3.86%17.72M | 276.12%35.16M | 243.46%17.06M | -69.25%9.35M | 7.95%4.97M | 51.68%30.4M | 20,818.18%4.6M | 47.88%20.04M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 200.00%3K | 25.00%5K | -66.67%1K | -60.00%4K | -50.00%3K | -65.52%10K | -33.33%6K | -14.71%29K | -18.18%9K | -85.02%34K |
| Sale of fixed assets | --97K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | -12,098.94%-11.47M | 60.65%-255K | 81.68%-94K | 77.94%-648K | 82.92%-513K | 82.02%-2.94M | 78.65%-3M | 37.90%-16.34M | -1,717.05%-14.06M | -299.17%-26.31M |
| Net cash from investment operations | -12,122.58%-11.37M | 61.18%-250K | 81.76%-93K | 78.01%-644K | 82.98%-510K | 82.05%-2.93M | 78.68%-3M | 37.93%-16.31M | -1,742.07%-14.06M | -312.87%-26.28M |
| Net cash before financing | -282.40%-32.15M | -30.41%24.02M | 6.49%17.63M | 437.63%34.52M | 739.83%16.55M | -54.43%6.42M | 120.85%1.97M | 325.91%14.09M | -1,175.71%-9.45M | -186.77%-6.24M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | --1.1M | --1.1M | ---- | ---- | --4.7M | ---- | ---- | ---- | 462.88%28.14M |
| Refund | ---- | 19.77%-10.17M | -88.32%-10.22M | -3,765.85%-12.68M | -1,677.91%-5.43M | -109.67%-328K | 103.58%344K | --3.39M | ---9.61M | ---- |
| Issuing shares | --39.38M | --14.99M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -137.06%-4.13M | ---- |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --16.99M | ---- |
| Net cash from financing operations | 259.19%30.25M | 65.72%-11.98M | -14.77%-19M | -83.83%-34.94M | -34.71%-16.56M | 4.04%-19.01M | -265.74%-12.29M | -229.01%-19.81M | -399.26%-3.36M | 166.76%15.36M |
| Effect of rate | -509.11%-2.16M | -290.87%-397K | 137.03%527K | -71.39%208K | -688.02%-1.42M | 1,414.58%727K | 16.35%242K | 113.68%48K | 200.48%208K | 44.64%-351K |
| Net Cash | -38.92%-1.91M | 2,913.08%12.04M | -68,500.00%-1.37M | 96.60%-428K | 99.98%-2K | -120.05%-12.59M | 19.47%-10.32M | -162.74%-5.72M | -806.15%-12.81M | 157.66%9.12M |
| Begining period cash | 525.88%13.86M | -9.04%2.21M | -9.04%2.21M | -82.97%2.43M | -82.97%2.43M | -28.41%14.3M | -28.41%14.3M | 78.28%19.97M | 78.28%19.97M | -59.49%11.2M |
| Cash at the end | 615.49%9.8M | 525.88%13.86M | 35.68%1.37M | -9.04%2.21M | -76.09%1.01M | -82.97%2.43M | -42.69%4.22M | -28.41%14.3M | -23.13%7.36M | 78.28%19.97M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm Limited | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.